FDA Drug Application (020780) for CIPRO by BAYER HLTHCARE

Back to FDA Applications sponsored by BAYER HLTHCARE

Application Number020780
Product Number001
FormFOR SUSPENSION;ORAL
Dosage250MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCIPRO
Active IngredientCIPROFLOXACIN



Back to FDA Applications sponsored by BAYER HLTHCARE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.